Micro-RNA Expression Profiles in Localised Prostate Cancer

Wuerzburg University Hospital

Overview

Recurrence free survival The patients will be followed in regular time intervals in accordance with the EAU-Guidelines (2010) and the S-3 Guideline for Prostate cancer of the German Urological Association. Data will be updated once yearly for until death.

Study Type

OBSERVATIONAL

Conditions

Prostate Cancer Radical Prostatectomy

Eligibility

Sex: MALEMin age: 35 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 35 Years to 80 Years * Male * Patients with clinically localised high risk prostate cancer Exclusion Criteria: \-

Outcomes

Primary Outcomes

Recurrence free survival

The patients will be followed in regular time intervals in accordance with the EAU-Guidelines (2010) and the S-3 Guideline for Prostate cancer of the German Urological Association.

Time frame: Up to 120 months. From date of inclusion until date of death from any cause

Secondary Outcomes

Cancer specific survival

Time frame: Up to 120 months. From date of inclusion until date of death from any cause

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.